IN2014MN00246A - - Google Patents

Info

Publication number
IN2014MN00246A
IN2014MN00246A IN246MUN2014A IN2014MN00246A IN 2014MN00246 A IN2014MN00246 A IN 2014MN00246A IN 246MUN2014 A IN246MUN2014 A IN 246MUN2014A IN 2014MN00246 A IN2014MN00246 A IN 2014MN00246A
Authority
IN
India
Prior art keywords
expression
gene therapy
invention concerns
recombinant baculovirus
therapy vectors
Prior art date
Application number
Other languages
English (en)
Inventor
Lionel Galibert
Otto Wilhelm Merten
Aurélien Jacob
Original Assignee
Genethon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genethon filed Critical Genethon
Publication of IN2014MN00246A publication Critical patent/IN2014MN00246A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/50—Vectors for producing vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2999/00—Further aspects of viruses or vectors not covered by groups C12N2710/00 - C12N2796/00 or C12N2800/00
    • C12N2999/007—Technological advancements, e.g. new system for producing known virus, cre-lox system for production of transgenic animals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN246MUN2014 2011-07-27 2012-07-27 IN2014MN00246A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1156878A FR2978456B1 (fr) 2011-07-27 2011-07-27 Systeme baculoviral pour l'expression d'un vecteur de therapie genique
PCT/FR2012/051791 WO2013014400A1 (fr) 2011-07-27 2012-07-27 Systeme baculoviral pour l'expression d'un vecteur de therapie genique

Publications (1)

Publication Number Publication Date
IN2014MN00246A true IN2014MN00246A (fr) 2015-09-25

Family

ID=46785752

Family Applications (1)

Application Number Title Priority Date Filing Date
IN246MUN2014 IN2014MN00246A (fr) 2011-07-27 2012-07-27

Country Status (16)

Country Link
US (2) US10017783B2 (fr)
EP (1) EP2737072B1 (fr)
KR (1) KR20140049040A (fr)
CN (1) CN103827306B (fr)
AU (1) AU2012288681B2 (fr)
BR (1) BR112014001859A2 (fr)
CA (1) CA2843042C (fr)
DK (1) DK2737072T3 (fr)
ES (1) ES2666278T3 (fr)
FR (1) FR2978456B1 (fr)
IN (1) IN2014MN00246A (fr)
NO (1) NO2737072T3 (fr)
PL (1) PL2737072T3 (fr)
PT (1) PT2737072T (fr)
SG (1) SG2014006373A (fr)
WO (1) WO2013014400A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10907130B2 (en) 2014-11-05 2021-02-02 Research Institute At Nationwide Children's Hospital Methods and materials for producing recombinant viruses in eukaryotic microalgae
US11708585B2 (en) * 2018-12-28 2023-07-25 Wuhan Institute Of Physics And Mathematics, Chinese Academy Of Sciences Method, system and recombinant bacmid for preparation of recombinant adeno-associated virus
CN109609552B (zh) * 2018-12-28 2020-04-14 中国科学院武汉物理与数学研究所 重组腺相关病毒的制备方法、***及重组杆粒
KR102272651B1 (ko) * 2019-03-28 2021-07-02 충북대학교 산학협력단 외래단백질의 발현량과 발현시간이 증대된 배큘로바이러스
JP2023538925A (ja) * 2020-08-17 2023-09-12 杭州金唯生物科技有限公司 アデノ随伴ウイルスの収量を増加させるための核酸構築物及びその構築方法
CN112852882A (zh) * 2021-02-04 2021-05-28 中吉智药(南京)生物技术有限公司 一种杆状病毒感染昆虫细胞生产aav基因药物的***及方法
CN114369624B (zh) * 2021-12-30 2023-07-14 华南农业大学 一种降低病毒感染导致的昆虫细胞凋亡的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042361A2 (fr) 2001-11-09 2003-05-22 Government Of The United States Of America, Department Of Health And Human Services Production d'un virus adeno-associe dans des cellules d'insectes
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
EP1534845A1 (fr) * 2002-09-04 2005-06-01 Polymun Scientific Immunbiologische Forschung GmbH Obtention de virus recombines de la grippe a l'aide de vecteurs generateurs de baculovirus
JP4597188B2 (ja) * 2004-03-09 2010-12-15 アイトゲネシシェ・テヒニーシェ・ホッホシューレ・チューリッヒ 多タンパク質適用のための新規発現ツール
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
GB0820631D0 (en) 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
WO2010114948A2 (fr) 2009-04-02 2010-10-07 University Of Florida Research Foundation, Inc. Système inductible de production à haut rendement de vecteurs recombinants dérivés de virus adéno-associés (raav)
EP2292781A1 (fr) * 2009-08-17 2011-03-09 Genethon Production des produits biopharmaceutiques à base de Baculovirus dépourvus de virions baculoviraux contaminants

Also Published As

Publication number Publication date
BR112014001859A2 (pt) 2017-02-21
PL2737072T3 (pl) 2018-08-31
DK2737072T3 (en) 2018-05-22
WO2013014400A1 (fr) 2013-01-31
CA2843042C (fr) 2020-07-21
NO2737072T3 (fr) 2018-07-14
US20180305717A1 (en) 2018-10-25
CN103827306B (zh) 2018-10-09
SG2014006373A (en) 2014-03-28
US10017783B2 (en) 2018-07-10
CN103827306A (zh) 2014-05-28
AU2012288681B2 (en) 2017-08-17
EP2737072B1 (fr) 2018-02-14
FR2978456B1 (fr) 2015-02-20
FR2978456A1 (fr) 2013-02-01
ES2666278T3 (es) 2018-05-03
PT2737072T (pt) 2018-05-08
KR20140049040A (ko) 2014-04-24
AU2012288681A1 (en) 2014-03-13
EP2737072A1 (fr) 2014-06-04
CA2843042A1 (fr) 2013-01-31
US20140349374A1 (en) 2014-11-27
US10767192B2 (en) 2020-09-08

Similar Documents

Publication Publication Date Title
IN2014MN00246A (fr)
NZ630800A (en) Methods of preparing substituted nucleotide analogs
UY34780A (es) Vectores virales para el tratamiento de distrofia retiniana
IN2014CN00688A (fr)
HK1196849A1 (en) Recombinant microorganism for the production of useful metabolites
MY170713A (en) Treatment protocol of diabetes type 2
GB201103062D0 (en) Method
IN2015DN00598A (fr)
MX370649B (es) Proceso para la preparacion de teneligliptina.
MX365621B (es) Nueva combinacion.
IN2014DN06964A (fr)
IN2014DN07996A (fr)
HK1201560A1 (en) Reduced genome bacteria with improved genetic stability
SG191332A1 (en) Recombinant mycobacterium as a vaccine
EP2925753A4 (fr) Nouveaux polymorphes de l'azilsartan médoxomil
AP2014007650A0 (en) Inhibition of viral gene expression
IN2012DN01929A (fr)
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
IN2014DN10209A (fr)
SG11201402476XA (en) Promoter derived from human gene
MX2014002378A (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
WO2014064714A3 (fr) Procédé de préparation de chlorhydrate de lurasidone
ZA201306342B (en) The treatment of viral infections
EP2690171A4 (fr) Alsv recombinant pour la prévention d'une infection virale pathogène d'une plante
EP2739738A4 (fr) Utilisation d'une intégrase pour l'expression génique ciblée